🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the immunogenicity and the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-20
Trial ID
NCT00385840
Treatments Being Tested
This study is designed to assess the safety and immunogenicity of GlaxoSmit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01196988
Treatments Being Tested
The purpose of this phase IIb study is to demonstrate the consistency of th...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-27
Trial ID
NCT00321763
Treatments Being Tested
In order to find the formulation leading to a maximal increase of the immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-05
Trial ID
NCT00540228
Treatments Being Tested
The purpose of the study is to evaluate the safety of GSK Biologicals' infl...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-15
Trial ID
NCT00992784
Treatments Being Tested
This study is designed to assess the safety and immunogenicity of a GSK Bio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01204671
Treatments Being Tested
This study is designed to assess the immunogenicity, reactogenicity and saf...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01190215
The aim of this study is to evaluate the immune response and the safety of ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01160237
Treatments Being Tested
This study is designed to test the immunogenicity and reactogenicity of the...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-16
Trial ID
NCT00920374
Treatments Being Tested
The purpose of this study is to evaluate the immune response and safety of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05-11
Trial ID
NCT00321373
Treatments Being Tested